Developing mRNA medicines to restore protein function.

We are a leading mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.

Learn More

Translate Bio

We are pioneering the translation of mRNA therapeutics into transformative medicines.

Watch the Video

Recent News

08.06 2020
Translate Bio Announces Second Quarter 2020 Financial Results and Reviews Recent Progress
07.20 2020
Translate Bio Announces Closing of Expanded Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for All Infectious Diseases
06.26 2020
Translate Bio Announces Pricing of Public Offering of Common Stock
06.24 2020
Translate Bio Announces Proposed Public Offering of Common Stock

View All

@TranslateBio